As the global economy mends, the 2021 growth of Pediatric Clinical Trials will have significant change from previous year. According to our (LP Information) latest study, the global Pediatric Clinical Trials market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Pediatric Clinical Trials market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Pediatric Clinical Trials market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pediatric Clinical Trials market, reaching US$ million by the year 2028. As for the Europe Pediatric Clinical Trials landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pediatric Clinical Trials players cover IQVIA Holdings, Inc., Parexel International, CenterWatch, and Syneos Health, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Clinical Trials market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Pre-Clinical Phase
Phase I
Phase II
Phase III
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Neuropsychiatric Conditions
Infectious Diseases
Respiratory Diseases
Cardiovascular Diseases
Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
IQVIA Holdings, Inc.
Parexel International
CenterWatch
Syneos Health
Charles River Laboratories
Covance Inc.
ICON Plc.
Pharmaceutical Product Development, LLC.
Genentech (Roche)
Pfizer
Bristol-Myers Squibb
GlaxoSmithKline
Sanofi S.A.
Novartis AG
Johnson & Johnson
Shire (Takeda)